News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neurowave Medical Technologies LLC and Alaven Pharmaceutical LLC Announce Licensing Agreement for Medical Device for the Treatment of Pregnancy Related Nausea and Vomiting (NVP)



12/17/2009 9:21:51 AM

CHICAGO--(BUSINESS WIRE)--Neurowave Medical Technologies™ (“NMT”) and Alaven® Pharmaceutical (“Alaven”) have entered into an exclusive licensing agreement under which Alaven will commercialize NMT’s patented prescription neuromodulation pulse generator device for the treatment of pregnancy induced nausea and vomiting (“NVP”) in the United States.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES